These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2725849)

  • 1. Dihydropyridine calcium channel antagonists as antidepressant drugs in mice and rats.
    Czyrak A; Mogilnicka E; Maj J
    Neuropharmacology; 1989 Mar; 28(3):229-33. PubMed ID: 2725849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydropyridine calcium channel antagonists reduce immobility in the mouse behavioral despair test; antidepressants facilitate nifedipine action.
    Mogilnicka E; Czyrak A; Maj J
    Eur J Pharmacol; 1987 Jun; 138(3):413-6. PubMed ID: 3622617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.
    Bourson A; Moser PC
    Psychopharmacology (Berl); 1990; 100(2):168-72. PubMed ID: 1689500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAY K 8644 enhances immobility in the mouse behavioral despair test, an effect blocked by nifedipine.
    Mogilnicka E; Czyrak A; Maj J
    Eur J Pharmacol; 1988 Jul; 151(2):307-11. PubMed ID: 2458947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacological profile of mesterolone.
    Baran L; Przegaliński E
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differential effects of calcium channel blockers in the behavioural despair test in mice.
    Srivastava SK; Nath C
    Pharmacol Res; 2000 Oct; 42(4):293-7. PubMed ID: 10987986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant activity of S-adenosyl-L-methionine in mice and rats.
    Czyrak A; Rogóz Z; Skuza G; Zajaczkowski W; Maj J
    J Basic Clin Physiol Pharmacol; 1992; 3(1):1-17. PubMed ID: 1504060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
    Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
    Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some behavioral effects of repeated administration of calcium channel antagonists.
    Czyrak A; Mogilnicka E; Siwanowicz J; Maj J
    Pharmacol Biochem Behav; 1990 Mar; 35(3):557-60. PubMed ID: 2160087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant properties of some phosphodiesterase inhibitors.
    Przegaliński E; Bigajska K
    Pol J Pharmacol Pharm; 1983; 35(3):233-40. PubMed ID: 6194518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
    Biała G
    Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The central action of carbamazepine as a potential antidepressant drug.
    Maj J; Chojnacka-Wójcik E; Lewandowska A; Tatarczyńska E; Wiczyńska B
    Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some central pharmacological effects of (+)- and (-)-oxaprotiline.
    Maj J; Rogóź Z; Skuza G; Sowińska H
    J Neural Transm Gen Sect; 1990; 80(2):129-43. PubMed ID: 2317315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators.
    Cohen C; Perrault G; Sanger DJ
    Behav Pharmacol; 1997 Nov; 8(6-7):629-38. PubMed ID: 9832975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural pharmacology of imidazole, a potential antidepressant agent.
    Ferrari F
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):303-12. PubMed ID: 4062441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropyridine calcium channel antagonists disrupt migrating myoelectric complexes and counteract intestinal disorders associated with morphine withdrawal diarrhea.
    Thollander M; Hellström PM; Svensson TH
    Scand J Gastroenterol; 1993 Feb; 28(2):137-44. PubMed ID: 8441907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium channel blockers as antidepressants--a property of the class or of the individual preparation?].
    Kozlovskiĭ VL; Prakh'e IV
    Eksp Klin Farmakol; 1994; 57(1):17-20. PubMed ID: 8142855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antihistaminic drugs in tests for antidepressant action.
    Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):321-35. PubMed ID: 6119682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The new versus the old antidepressant drugs: a comparative study of their psychopharmacological profiles (author's transl)].
    Bourin M; Puech AJ; Chermat R; Doare L; Poncelet M; Simon P
    Encephale; 1981; 7(3):235-42. PubMed ID: 7285851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic dihydropyridine treatment can reverse the behavioural consequences of and prevent adaptations to, chronic ethanol treatment.
    Whittington MA; Dolin SJ; Patch TL; Siarey RJ; Butterworth AR; Little HJ
    Br J Pharmacol; 1991 Jul; 103(3):1669-76. PubMed ID: 1834295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.